Filing metadata

Accession number
0001415889-25-012031
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
May 05, 2025
Reporting period
May 01, 2025
Description
Insider transaction

Explore SEC Filings Hub